Skip to main content
Search Button
Canada Kobo store Gift Cards Help

Rakuten Kobo

Wishlist

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...


“jorge cortes”

Showing 1 - 12 of 12 results for “jorge cortes”
Skip side bar filters

  • Chronic Myeloid Leukemia

    Edited by Jorge Cortes, Michael Deininger ...
    Chronic Myeloid Leukemia (CML) remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level and has been used by researchers to develop a variety of therapies and therapeutic assessment methods. This concise, readable guide assembles and synthesizes the latest developments and trends in the treatmen ... Read more

    $119.54 CAD

People who read this also enjoyed

  • Pharmacogenomics An Introduction and Clinical Perspective

    by Joseph S. Bertino, Angela Kashuba, Joseph D. Ma, Uwe Fuhr, C. Lindsay DeVane ...
    A COMPLETE INTRODUCTORY TEXT TO THE FIELD OF PHARMACOGENOMICSThe only pharmacogenomics resource to feature a global author team comprised of PharmDs, MDs, PhDs and social scientists, Pharmacogenomics offers an essential, highly accessible survey of this dynamic discipline. You will find thorough coverage of all need-to-know topics, from individual molecules to systemic diseases, plus an ... Read more

    $97.99 CAD

  • Translational Endocrinology of Bone

    Reproduction, Metabolism, and the Central Nervous System

    Edited by Gerard Karsenty ...
    The use of model organisms together with the power of genetics has profoundly affected our understanding of the physiology of one organ, the skeleton, in two distinct but complementary ways. This is the first translational reference to focus on these major conceptual advances in bone biology and their development in the clinic. Several advances have already been translated into therapies and ... Read more

    $122.99 CAD

  • Translational Cancer Research for Surgeons, An Issue of Surgical Oncology Clinics

    by William G. Cance, MD ...
    Series Book Volume 22-4 - The Clinics: Surgery
    This issue of the Surgical Oncology Clinics of North America, Guest Edited by Dr. William G. Cance, is devoted to Translational Cancer Research for Surgeons. Translational Cancer research aims to move bench research to the bedside by applying basic science toward potential therapies. This issue will present the concepts of translational research and development of targeted therapeutics, and its ... Read more

    $92.99 CAD

  • Cancer Immunotherapy

    Paradigms, Practice and Promise

    Edited by Tyler J. Curiel ...
    Series series Biomedical and Life Sciences (R0)
    This work will provide a historical perspective on tumor immunotherapy, discuss fundamental mechanisms of failed tumor rejection, look at passive strategies to boost anti-tumor immunity, as well as have an in-depth look at active strategies to boost anti-tumor immunity. ... Read more

    $179.99 CAD

  • New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America

    by Franco Muggia ...
    Series Book Volume 26-3 - The Clinics: Internal Medicine
    Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways. ... Read more

    $87.99 CAD

  • Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

    by Jennifer R. Brown, MD ...
    Series Book Volume 27-2 - The Clinics: Internal Medicine
    This issue of Hematology/Oncology Clinics is edited by Dr. Jennifer Brown and focuses on Chronic Lymphocytic Leukemia. Article topics include: What Have Recent Genomic Advances Taught us About CLL?, Biology of CLL in Different Microenvironments,What is the Significance of Stereotyped BCRs in CLL?, Understanding Immunodeficiency in CLL, MBL vs CLL: How Important is the Distinction?, Risk ... Read more

    $92.99 CAD

  • Targeted Therapy in Translational Cancer Research

    by Maurie Markman, Ernest Hawk, Robert C. Bast Jr. ...
    Series series Translational Oncology
    Targeted Therapy in Translational Cancer Research for the Translational Oncology series provides a comprehensive overview of recent developments in our understanding of tumor biology, elucidates the roles of targets and pathways involved in carcinogenesis, and describes current state-of-the-art anticancer therapy, as well as the most promising areas of translational research and targeted therapy ... Read more

    $179.99 CAD

  • Cancer Biology Review

    A Case-Based Approach

    by Walter M. Stadler, MD ...
    Utilizing the teaching value of real-world case discussions, Cancer Biology Review presents the principles of cancer biology in a clear and memorable manner, allowing the clinician to relate the cases shown in the book to those seen in practice. Focusing on ten topics in cancer biology for which there have been major changes in fundamental understanding, the authors provide a concise overview of ... Read more

    $101.99 CAD

  • Lysophospholipid Receptors

    Signaling and Biochemistry

    by Timothy Hla, Sarah Spiegel, Wouter Moolenaar ...
    The current state of the science supporting new research in lysophospholipidsThe study of lysophospholipids exploded with the discovery of cell surface receptors on both lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P). Since then, thousands of original research reports-ranging from fundamental cell signaling to the physiology and pathophysiology of individual organ systems-have ... Read more

    $191.99 CAD

  • The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America

    by Ann Mullally, MD ...
    Series Book Volume 31-4 - The Clinics: Internal Medicine
    This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next ... Read more

    $102.99 CAD

  • Renal Cell Carcinoma

    Translational Biology, Personalized Medicine, and Novel Therapeutic Targets

    Edited by Robert A. Figlin, W. Kimryn Rathmell, Brian I. Rini ...
    Series series Biomedical and Life Sciences (R0)
    This book provides a comprehensive look at renal cell carcinoma, exploring its biology as well as current and future molecular targets for renal cancer carcinoma. ... Read more

    $179.99 CAD